References

1. Brichard B. Histiocytose de langerhans: nouveautés concernant la compréhension d'une maladie énigmatique= Langerhans cell histiocytosis. Louvain med. 2000; 119(6): 127-133. PubMed | Google Scholar


2. Howarth DM, Gilchrist GS, Mullan BP, Wiseman GA, Edmonson JH, Schomberg PJ. Langerhans cell histiocytosis: diagnosis, natural history, management, and outcome. Cancer. 1999 May 15;85(10):2278-90. PubMed | Google Scholar


3. Kilpatrick SE, Wenger DE, Gilchrist GS, Shives TC, Wollan PC, Unni KK. Langerhans' cell histiocytosis (histiocytosis X) of bone: A clinicopathologic analysis of 263 pediatric and adult cases. Cancer. 1995 Dec 15;76(12):2471-84. PubMed | Google Scholar


4. Lahey E. Histiocytosis x--an analysis of prognostic factors. J Pediatr. 1975 Aug;87(2):184-9. PubMed | Google Scholar


5. Arceci RJ, Brenner MK, Pritchard J. Controversies and new approaches to treatment of Langerhans cell histiocytosis. Hematol Oncol Clin North Am. 1998 Apr;12(2):339-57. PubMed | Google Scholar


6. Broadbent V, Gardner H. Current therapy for Langerhans cell histiocytosis. Hematol Oncol Clin North Am. 1998; 12: 327-338. PubMed | Google Scholar


7. Bernstrand C, Björk O, Ahström L, Henter JI. Intralesional steroids in Langerhans cell histiocytosis of bone. Acta Paediatr. 1996 Apr;85(4):502-4. PubMed | Google Scholar


8. Yasko AW, Fanning CV, Ayala AG,Carrasco CH, Murray JA . Percutaneous techniques for the diagnosis and treatment of localized Langerhans-cell histiocytosis (eosinophilic granuloma of bone). J Bone Joint Surg Am. 1998 Feb;80(2):219-2. PubMed | Google Scholar